DK0896533T3 - Pentafluorbenzensulfonamider og analoger - Google Patents
Pentafluorbenzensulfonamider og analogerInfo
- Publication number
- DK0896533T3 DK0896533T3 DK97907843T DK97907843T DK0896533T3 DK 0896533 T3 DK0896533 T3 DK 0896533T3 DK 97907843 T DK97907843 T DK 97907843T DK 97907843 T DK97907843 T DK 97907843T DK 0896533 T3 DK0896533 T3 DK 0896533T3
- Authority
- DK
- Denmark
- Prior art keywords
- pentafluorobenzene
- sulfonamides
- analogues
- agents
- compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/14—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems
- C07D319/16—1,4-Dioxanes; Hydrogenated 1,4-dioxanes condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D319/18—Ethylenedioxybenzenes, not substituted on the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/18—Sulfonamides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/21—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/22—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms
- C07C311/29—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound oxygen atoms having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/46—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having at least one of the nitrogen atoms, not being part of nitro or nitroso groups, further bound to other hetero atoms
- C07C323/49—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton having at least one of the nitrogen atoms, not being part of nitro or nitroso groups, further bound to other hetero atoms to sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
- C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
- C07D317/66—Nitrogen atoms not forming part of a nitro radical
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US60543196A | 1996-02-22 | 1996-02-22 | |
PCT/US1997/002926 WO1997030677A2 (en) | 1996-02-22 | 1997-02-22 | Pentafluorobenzenesulfonamides and analogs |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0896533T3 true DK0896533T3 (da) | 2004-01-26 |
Family
ID=24423637
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK97907843T DK0896533T3 (da) | 1996-02-22 | 1997-02-22 | Pentafluorbenzensulfonamider og analoger |
Country Status (13)
Country | Link |
---|---|
US (4) | US5880151A (da) |
EP (2) | EP1334719A3 (da) |
JP (1) | JP3421349B2 (da) |
AT (1) | ATE249213T1 (da) |
AU (1) | AU711159B2 (da) |
CA (1) | CA2244785C (da) |
DE (1) | DE69724777T2 (da) |
DK (1) | DK0896533T3 (da) |
EA (1) | EA001367B1 (da) |
ES (1) | ES2205183T3 (da) |
NZ (1) | NZ331941A (da) |
PT (1) | PT896533E (da) |
WO (1) | WO1997030677A2 (da) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6613804B2 (en) | 1993-05-20 | 2003-09-02 | Encysive Pharmaceuticals, Inc. | Biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin |
NZ331941A (en) | 1996-02-22 | 2000-04-28 | Tularik Inc | Pentafluorobenzenesulfonamides and analogs and use in regulation of LDL receptor synthesis |
DK0939627T3 (da) | 1996-07-19 | 2003-10-13 | Tularik Inc | Pentaflourbenzensulfonamider og analoger |
CA2496680A1 (en) * | 1997-04-28 | 1998-11-05 | Encysive Pharmaceuticals Inc. | Sulfonamide compounds and salts for treatment of endothelin-mediated disorders |
JP4253126B2 (ja) * | 1998-01-29 | 2009-04-08 | アムジェン インコーポレイテッド | Ppar−ガンマ調節剤 |
US6583157B2 (en) | 1998-01-29 | 2003-06-24 | Tularik Inc. | Quinolinyl and benzothiazolyl modulators |
DE69911017T2 (de) | 1998-06-25 | 2004-07-08 | Tularik, Inc., South San Francisco | Arylsulfonanilid-phosphate |
US6153585A (en) * | 1998-07-20 | 2000-11-28 | Tularik Inc. | Arylsulfonanilide derivatives |
CN100335461C (zh) | 1998-09-23 | 2007-09-05 | 图拉里克公司 | 芳基磺酰基苯胺脲 |
EP1285911A3 (en) * | 1998-09-23 | 2003-03-26 | Tularik Inc. | Arylsulfonanilide ureas |
AU731777B2 (en) * | 1998-11-30 | 2001-04-05 | Nihon Nohyaku Co., Ltd. | Aniline derivative and process for producing the same |
US7041691B1 (en) | 1999-06-30 | 2006-05-09 | Amgen Inc. | Compounds for the modulation of PPARγ activity |
DE60019937T2 (de) | 1999-07-29 | 2006-05-04 | Amgen, Inc., Thousands Oaks | Kombinationstherapie mit Pentafluorobenzolsulfonamid und Platin-Derivaten |
US6306615B1 (en) | 1999-08-19 | 2001-10-23 | Tularik Inc. | Detection method for monitoring β tubulin isotype specific modification |
WO2001082916A2 (en) | 2000-05-03 | 2001-11-08 | Tularik Inc. | Combination therapeutic compositions and methods of use |
US6432427B1 (en) * | 2000-06-30 | 2002-08-13 | Unilever Hope & Personal Care Usa, Division Of Conopco, Inc. | Cosmetic compositions containing substituted sulfonamide derivatives |
AU2002234165A1 (en) | 2000-11-03 | 2002-05-27 | Tularik, Inc. | Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents |
US20050250854A1 (en) * | 2000-11-03 | 2005-11-10 | Amgen Inc. | Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents |
US6646009B2 (en) | 2001-02-28 | 2003-11-11 | Temple University — Of Commonwealth System of Higher Education | N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof |
US6599866B2 (en) | 2001-04-20 | 2003-07-29 | Exxonmobil Research And Engineering Company | Servo valve erosion inhibited aircraft hydraulic fluids |
EP1403255A4 (en) * | 2001-06-12 | 2005-04-06 | Sumitomo Pharma | INHIBITORS OF RHO KINASE |
ATE517626T1 (de) * | 2002-02-28 | 2011-08-15 | Univ Temple | Aminosubstituierte sulphonanilide und ihre derivate zur behandlung von proliferativen erkrankungen |
FR2836914B1 (fr) | 2002-03-11 | 2008-03-14 | Aventis Pharma Sa | Indazoles substitues, compositions les contenant, procede de fabrication et utilisation |
US6989399B2 (en) * | 2002-08-01 | 2006-01-24 | Bristol-Myers Squibb Company | Antiamyloid phenylsulfonamides: N-alkanol derivatives |
US7223761B2 (en) | 2003-10-03 | 2007-05-29 | Amgen Inc. | Salts and polymorphs of a potent antidiabetic compound |
US20060173019A1 (en) * | 2005-01-14 | 2006-08-03 | Solomon Ungashe | Heteroaryl sulfonamides and CCR2 |
US7622583B2 (en) | 2005-01-14 | 2009-11-24 | Chemocentryx, Inc. | Heteroaryl sulfonamides and CCR2 |
FR2884820B1 (fr) * | 2005-04-25 | 2007-07-27 | Merck Sante Soc Par Actions Si | Nouveaux inhibiteurs specifiques de la caspase-10 |
KR101790908B1 (ko) | 2007-07-12 | 2017-10-26 | 케모센트릭스, 인크. | 염증의 치료를 위한 ccr2 조절물질로서 융합된 헤테로아릴 피리딜과 페닐 벤젠술폰아마이드 |
KR20190088513A (ko) | 2016-11-23 | 2019-07-26 | 케모센트릭스, 인크. | 국소 분절 사구체경화증의 치료 방법 |
CN106928101A (zh) * | 2017-03-06 | 2017-07-07 | 中国药科大学 | 苯磺酰胺类ido1抑制剂、其制备方法及应用 |
JP2020536919A (ja) | 2017-10-11 | 2020-12-17 | ケモセントリックス, インコーポレイテッド | Ccr2アンタゴニストによる巣状分節性糸球体硬化症の治療 |
WO2021099842A1 (en) * | 2019-11-22 | 2021-05-27 | 2692372 Ontario Inc. | Pentafluorobenzenesulfonamide derivatives and uses thereof |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1955207A (en) * | 1931-09-16 | 1934-04-17 | Ig Farbenindustrie Ag | Mothproofing agent |
US2402623A (en) * | 1943-06-24 | 1946-06-25 | Rohm & Haas | Nu-nitroaryl haloarylsulphonamides |
CH362688A (de) * | 1957-09-10 | 1962-06-30 | Geigy Ag J R | Verfahren zur Herstellung von neuen Arylsulfonarylamiden |
GB1242057A (en) * | 1968-07-04 | 1971-08-11 | Ici Ltd | Derivatives of 4-hydroxytetrafluoropyridine and the use thereof as plant growth regulators |
NL174644C (nl) | 1970-04-13 | 1984-07-16 | Minnesota Mining & Mfg | Werkwijze ter bereiding van een herbicide verbinding; tevens werkwijze voor de bereiding van een preparaat met herbicide werking. |
DE3000377A1 (de) * | 1980-01-07 | 1981-07-09 | Boehringer Mannheim Gmbh, 6800 Mannheim | Neue sulfonamide, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel |
DE3623184A1 (de) * | 1986-07-10 | 1988-01-14 | Kali Chemie Ag | Verfahren zur herstellung von n-fluorsulfonamiden |
DE3632329A1 (de) * | 1986-09-24 | 1988-03-31 | Bayer Ag | Substituierte phenylsulfonamide |
US4883914A (en) * | 1987-08-17 | 1989-11-28 | American Cyanamid Company | Benzenesulfonyl carboxamide compounds useful as herbicidal agents |
DE3804990A1 (de) * | 1988-02-18 | 1989-08-31 | Basf Ag | Herbizid wirksame, heterocyclisch substituierte sulfonamide |
FR2645537B1 (fr) * | 1989-04-05 | 1994-03-04 | Fabre Medicament Pierre | Nouveaux sulfonamides derives d'acides benzocycliques ou benzoheterocycliques, leur preparation et leur application en therapeutique |
FR2665440B1 (fr) * | 1990-07-31 | 1994-02-04 | Lipha | Nouveaux cycloalkylsulfonamides substitues, procedes de preparation et medicaments les contenant. |
US5189211A (en) * | 1990-08-01 | 1993-02-23 | Taisho Pharmaceutical Co., Ltd. | Sulfonamide derivatives |
ATE167473T1 (de) * | 1990-08-20 | 1998-07-15 | Eisai Co Ltd | Sulfonamid-derivate |
CH681529A5 (da) | 1990-08-21 | 1993-04-15 | Alusuisse Lonza Services Ag | |
DE19581653T1 (de) * | 1994-05-25 | 1997-07-17 | Dow Chemical Co | Sulfonamide, verwendbar als Schmierstoffe in magnetischen Aufzeichnungsmedien |
WO1996040629A1 (en) | 1995-06-07 | 1996-12-19 | Sugen, Inc. | Tyrphostin-like compounds for the treatment of cell proliferative disorders or cell differentiation disorders |
NZ331941A (en) | 1996-02-22 | 2000-04-28 | Tularik Inc | Pentafluorobenzenesulfonamides and analogs and use in regulation of LDL receptor synthesis |
DK0939627T3 (da) * | 1996-07-19 | 2003-10-13 | Tularik Inc | Pentaflourbenzensulfonamider og analoger |
US5773236A (en) * | 1997-04-25 | 1998-06-30 | Molecule Probes, Inc. | Assay for glutathiane transferase using polyhaloaryl-substituted reporter molecules |
US6284923B1 (en) * | 1997-08-22 | 2001-09-04 | Tularik Inc | Substituted benzene compounds as antiproliferative and cholesterol lowering action |
WO1999024407A1 (en) | 1997-11-10 | 1999-05-20 | Array Biopharma, Inc. | Compounds which inhibit tryptase activity |
DE69911017T2 (de) * | 1998-06-25 | 2004-07-08 | Tularik, Inc., South San Francisco | Arylsulfonanilid-phosphate |
US6153585A (en) * | 1998-07-20 | 2000-11-28 | Tularik Inc. | Arylsulfonanilide derivatives |
DE60019937T2 (de) * | 1999-07-29 | 2006-05-04 | Amgen, Inc., Thousands Oaks | Kombinationstherapie mit Pentafluorobenzolsulfonamid und Platin-Derivaten |
AU2002234165A1 (en) * | 2000-11-03 | 2002-05-27 | Tularik, Inc. | Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents |
-
1997
- 1997-02-22 NZ NZ331941A patent/NZ331941A/xx unknown
- 1997-02-22 WO PCT/US1997/002926 patent/WO1997030677A2/en active IP Right Grant
- 1997-02-22 DK DK97907843T patent/DK0896533T3/da active
- 1997-02-22 CA CA002244785A patent/CA2244785C/en not_active Expired - Fee Related
- 1997-02-22 AT AT97907843T patent/ATE249213T1/de not_active IP Right Cessation
- 1997-02-22 PT PT97907843T patent/PT896533E/pt unknown
- 1997-02-22 EA EA199800752A patent/EA001367B1/ru unknown
- 1997-02-22 EP EP03009125A patent/EP1334719A3/en not_active Withdrawn
- 1997-02-22 ES ES97907843T patent/ES2205183T3/es not_active Expired - Lifetime
- 1997-02-22 DE DE69724777T patent/DE69724777T2/de not_active Expired - Lifetime
- 1997-02-22 JP JP53039797A patent/JP3421349B2/ja not_active Expired - Fee Related
- 1997-02-22 AU AU19739/97A patent/AU711159B2/en not_active Ceased
- 1997-02-22 EP EP97907843A patent/EP0896533B1/en not_active Expired - Lifetime
- 1997-07-18 US US08/896,827 patent/US5880151A/en not_active Expired - Lifetime
-
1999
- 1999-01-06 US US09/227,216 patent/US6121304A/en not_active Expired - Fee Related
-
2000
- 2000-08-07 US US09/633,740 patent/US6316484B1/en not_active Expired - Fee Related
-
2001
- 2001-10-05 US US09/972,743 patent/US7138418B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO1997030677A3 (en) | 1997-11-20 |
US7138418B2 (en) | 2006-11-21 |
AU1973997A (en) | 1997-09-10 |
CA2244785A1 (en) | 1997-08-28 |
JP2000505459A (ja) | 2000-05-09 |
EP0896533A2 (en) | 1999-02-17 |
AU711159B2 (en) | 1999-10-07 |
WO1997030677A2 (en) | 1997-08-28 |
US20020143036A1 (en) | 2002-10-03 |
NZ331941A (en) | 2000-04-28 |
EP0896533A4 (en) | 1999-04-28 |
US5880151A (en) | 1999-03-09 |
US6316484B1 (en) | 2001-11-13 |
DE69724777D1 (de) | 2003-10-16 |
EP1334719A3 (en) | 2003-09-24 |
ATE249213T1 (de) | 2003-09-15 |
PT896533E (pt) | 2004-02-27 |
EA001367B1 (ru) | 2001-02-26 |
DE69724777T2 (de) | 2004-07-15 |
ES2205183T3 (es) | 2004-05-01 |
CA2244785C (en) | 2003-12-02 |
US6121304A (en) | 2000-09-19 |
EP1334719A2 (en) | 2003-08-13 |
EP0896533B1 (en) | 2003-09-10 |
JP3421349B2 (ja) | 2003-06-30 |
EA199800752A1 (ru) | 1999-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0896533T3 (da) | Pentafluorbenzensulfonamider og analoger | |
NO2022019I1 (no) | Eribulin eller et farmasøytisk akseptabelt salt derav - forlenget SPC | |
DK0939627T3 (da) | Pentaflourbenzensulfonamider og analoger | |
HUP0101999A2 (hu) | 4-Hidroxi-kinolin-3-karboxamid- és -hidrazid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint e vegyületek alkalmazása | |
DE60009511D1 (de) | Nematizide trifluorbutene | |
DE60143984D1 (de) | Neue phenylalanin-derivate | |
BR9811099A (pt) | Inibidores de urocinase | |
DE60121461D1 (de) | Kondensierte pyridoindolderivate | |
FI920023A0 (fi) | Heteroarylpiperazinfoereningar som antipsykotiska aemnen. | |
TR200002542T2 (tr) | Meta-azasiklik amino benzoik asit bileşikleri ve bunların integrin antagonistleri olan türevleri | |
EA200100516A1 (ru) | Производные 3,3-биарилпиперидина и 2,2-биарилморфолина | |
TR200101979T2 (tr) | Antidepresyon tedavisi için 5HT1 antagonistleri. | |
BR0013292A (pt) | Derivados de benzenamina como anti-coagulantes | |
DK1250337T3 (da) | Substituerede homopiperidinylbenzimidazol-analoger som fundus-relaksanter | |
EA200100711A1 (ru) | Аналоги нуклеозида (варианты) и их применение, комбинация и способ лечения вирусных инфекций, фармацевтическая композиция | |
ES2168355T3 (es) | Derivados de bisulfuro de indano-2-mercaptoacetilamida utiles como inhibidores de la encefalinasa. | |
DK0420224T3 (da) | Anthihepatopatisk middel | |
ES2123728T3 (es) | Derivados de pirrolo-pirazina de actividad 5-ht3. | |
DK0520372T3 (da) | Inositol-phosphat-analoger som calciumantagonistiske stoffer | |
EA200001157A2 (ru) | Новые замещенные производные (дигидро)бензоксазина и (дигидро)бензотиазина, способ их получения и содержащие их фармацевтические композиции | |
HUP0002727A2 (hu) | Eljárás fibrinogén csökkentésére benzotiofénszármazékok felhasználásával | |
BR9915898A (pt) | Compostos, composição farmacêutica, e, utilização de um composto | |
ATE268768T1 (de) | Antithrombosemittel | |
PT1140932E (pt) | Derivados de 1,8-benzonaftiridina | |
ECSP972237A (es) | Derivados de 6,5 heterobiciclicos sustituidos |